SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000874716-24-000107
Filing Date
2024-05-10
Accepted
2024-05-10 16:00:23
Documents
16
Period of Report
2024-05-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K idxx-20240506.htm   iXBRL 8-K 52411
2 EX-10.1 exhibit101-jpconsultingagr.htm EX-10.1 62467
7 idxx-20240506_g1.jpg GRAPHIC 47794
  Complete submission text file 0000874716-24-000107.txt   395734

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idxx-20240506.xsd EX-101.SCH 2246
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT idxx-20240506_def.xml EX-101.DEF 14941
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idxx-20240506_lab.xml EX-101.LAB 26357
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idxx-20240506_pre.xml EX-101.PRE 15589
20 EXTRACTED XBRL INSTANCE DOCUMENT idxx-20240506_htm.xml XML 2863
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

IRS No.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 24934603
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)